↓ Skip to main content

34 th Hemophilia Symposium

Overview of attention for book
Cover of '34 th Hemophilia Symposium'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2002/2003 Survey)
  3. Altmetric Badge
    Chapter 2 Hemophilia in Austria — The Annual Survey of the Austrian Hemophilia Centers
  4. Altmetric Badge
    Chapter 3 Lithuanian Hemophilia Register: Update 2003
  5. Altmetric Badge
    Chapter 4 Guidelines for Treatment of Patients with Hemophilia and Inhibitors
  6. Altmetric Badge
    Chapter 5 Bolus Injection of Recombinant Factor VIIa (NovoSeven) can be More Effective than Continuous Infusion in Inhibitor Patients with Severe Hemophilia A
  7. Altmetric Badge
    Chapter 6 The Role of Therapy Regimen and Age at First Exposure on Inhibitor Development in Patients with Severe Hemophilia A
  8. Altmetric Badge
    Chapter 7 Presentation of the Inhibitor-Immunology-Study
  9. Altmetric Badge
    Chapter 8 Current Clinical Investigations Involving FEIBA
  10. Altmetric Badge
    Chapter 9 Major Orthopedic Reconstructions in an Inhibitor Patient — A Case Report
  11. Altmetric Badge
    Chapter 10 Total Hip Replacement in Patients with Severe Bleeding Disorders A 30 Years Single Center Experience
  12. Altmetric Badge
    Chapter 11 MRI Staging of Hemophilic Joints in Comparison with the Radiological Score and the Clinical Dates of Children and Young Adults
  13. Altmetric Badge
    Chapter 12 Orthopedic Knee Replacement in Hemophilic Patients
  14. Altmetric Badge
    Chapter 13 Treatment of Adults with Sepsis-Induced Coagulopathy and Purpura Fulminans with a Plasma-Derived Protein C Concentrate (Ceprotin)
  15. Altmetric Badge
    Chapter 14 Comparison of the Anticoagulant Action of Recombinant Human Activated Protein C in Cord with that in Adult Plasma
  16. Altmetric Badge
    Chapter 15 The Relationship between Protein C Activity and the Endogenous Thrombin Potential in Controls and Septic Patients
  17. Altmetric Badge
    Chapter 16 Antibodies Against Annexin V, Cardiolipin and β 2 -Glycoprotein 1 or APC-Resistance in Patients with Recurrent Miscarriage or In-Vitro-Fertilization-Failures
  18. Altmetric Badge
    Chapter 17 Diagnostics of Platelet Function Disorders by Lumi-Aggregometry — Results and Comparison of Methods
  19. Altmetric Badge
    Chapter 18 Management of a Premature Infant below 1500 g with Hemophilia A
  20. Altmetric Badge
    Chapter 19 Elevated Factor VIIIC: Ag in Children with Venous Thrombosis and Stroke — Preliminary Results of a Case-Control Study
  21. Altmetric Badge
    Chapter 20 Functional Disorders and Treatment Modalities in Hemophilic Children
  22. Altmetric Badge
    Chapter 21 HLA Profile in Acquired Hemophilia
  23. Altmetric Badge
    Chapter 22 Characterization of Polyclonal Factor VIII-Inhibitory Antibodies
  24. Altmetric Badge
    Chapter 23 Frequency and Inhibitor Risk of the Intron-1-Inversion Mutation in the German Hemophilia Population
  25. Altmetric Badge
    Chapter 24 Effect of FVIII on Clotting Time and Thrombin Potential in Tissue Factor-Activated Hemophilia A Plasma
  26. Altmetric Badge
    Chapter 25 Bleeding Tendency in Factor XI Deficiency: Report on two Families and the Detection of a Novel Mutation within the Factor XI Gene
  27. Altmetric Badge
    Chapter 26 Multiple Distal Pseudotumours in a Patient with Severe Hemophilia A and High Titer Inhibitors
  28. Altmetric Badge
    Chapter 27 HIV Resistance to Antiretroviral Therapy in Romania
  29. Altmetric Badge
    Chapter 28 Ileopsoas Hemophilic Pseudotumour with Externalized Bowel Fistulation
  30. Altmetric Badge
    Chapter 29 Reduction of Proteoglycan Synthesis in Chondrocytes Depending on Concentration and Duration of Iron Overload
  31. Altmetric Badge
    Chapter 30 Bleeding Tendency of Carriers of Hemophilia A — Dependent on the Age of the Carriers?
  32. Altmetric Badge
    Chapter 31 Clinical Investigation of Orthopedic Outcome in Patients with Severe Hemophilia Under Prophylactic Treatment. Disadvantage of a late Prophylactic Treatment?
  33. Altmetric Badge
    Chapter 32 Operative Treatment of Ankle Equinus Deformity in Hemophiliacs
  34. Altmetric Badge
    Chapter 33 Spontaneous Empyema of Joints and Staphylococcal Sepsis in a Patient with Severe Hemophilia A
  35. Altmetric Badge
    Chapter 34 The Role of VWF:Ag II in Patients with Acquired von Willebrand Disease
  36. Altmetric Badge
    Chapter 35 Contamination of Coagulation Factor Concentrates with Human Parvovirus Genotype 2 DNA is Less Frequent than Contamination with Genotype 1 (B19) DNA
  37. Altmetric Badge
    Chapter 36 The Hemophilia Assistant in Germany
  38. Altmetric Badge
    Chapter 37 “Need” in Hemophilia A — a Qualitative Study
  39. Altmetric Badge
    Chapter 38 Fit for Life — Fitness Levels of Young Hemophiliacs Today
  40. Altmetric Badge
    Chapter 39 The Austrian “Haemofit-Program” - a two Years work-out Experience of People with Hemophilia (PwH)
  41. Altmetric Badge
    Chapter 40 Methods for Testing Pharmacodynamic Variables of Hemophilia and Inhibitor Therapy: Thrombin Generation Assay and Other Tests
  42. Altmetric Badge
    Chapter 41 Immune Tolerance in an Inhibitor Patient with Severe Hemophilia A — Comparison of two Different Treatment Schedules Including Rituximab
  43. Altmetric Badge
    Chapter 42 The Endogenous Thrombin Potential as a Monitoring Parameter in a Patient with an Acquired Hemophilia A
  44. Altmetric Badge
    Chapter 43 Case report: 58-Year-Old Hemophilia A Patient with High-Titer Inhibitor Development and Introduction of a Multicenter PTP-Inhibitor Study
  45. Altmetric Badge
    Chapter 44 First Data of a Prospective Study About Incidence of Inhibitors During and After Continuous Infusion of Different Factor Concentrates Given During and After Surgical Procedures in Hemophilia A or B and von Willebrand Disease
  46. Altmetric Badge
    Chapter 45 Acquired Thrombophilia in Patients on Hemodialysis with Recurrent Vascular Access Thrombosis
  47. Altmetric Badge
    Chapter 46 Is Travelling a Risk Factor for Venous Thrombosis in Individuals with Factor V Leiden in Heterozygous Form?
  48. Altmetric Badge
    Chapter 47 Popliteal Artery Embolism in Abdominal Aortal Thrombus with Liver Abscesses Caused by Heterozygous Prothrombin Mutation with Protein S Deficiency and Factor VIII Elevation
  49. Altmetric Badge
    Chapter 48 Effect of the new Direct Thrombin Inhibitor Melagatran in Cord and Adult Plasma: an in-vitro Examination
  50. Altmetric Badge
    Chapter 49 Higher Concentrations of Heparin and Hirudin are Required to Inhibit Thrombin Generation in Tissue Factor-Activated Cord Compared to Adult Plasma
  51. Altmetric Badge
    Chapter 50 Molecular Genetic Analysis in Patients with Inherited Thrombophilia and Antithrombin, Protein C or Protein S Deficiency
  52. Altmetric Badge
    Chapter 51 Analysis of Thrombophilic Risk Factors in Patients Suffering from Ocular Thrombotic Complications
  53. Altmetric Badge
    Chapter 52 Protein C Concentrate for the Treatment of Veno Occlusive Disease in a boy with Nephroblastoma
  54. Altmetric Badge
    Chapter 53 Homozygous Factor X Gene Mutation Gly380Arg is Associated to Perinatal Intracranial Hemorrhage
  55. Altmetric Badge
    Chapter 54 Mutation Analysis of the C1 Inhibitor Gene
  56. Altmetric Badge
    Chapter 55 Novel and Recurrent Mutations in the Gamma-Glutamyl Carboxylase (GGCX) Gene
  57. Altmetric Badge
    Chapter 56 First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High Molecular Weight Kininogen Deficiency
  58. Altmetric Badge
    Chapter 57 Sequence of the rat Factor VIII cDNA
  59. Altmetric Badge
    Chapter 58 Mutation Profiling in Congenital FXIIIA Deficiency: Detection of 6 Novel Mutations
  60. Altmetric Badge
    Chapter 59 Functional Analysis of the Factor VIII B Domain
  61. Altmetric Badge
    Chapter 60 Expressing Recombinant Coagulation Factors in Yeast and Insect Cells
  62. Altmetric Badge
    Chapter 61 Long Term Optimisation of F8 Gene Mutation Screening by DHPLC
  63. Altmetric Badge
    Chapter 62 Expression Studies of Recombinant FVIII Proteins Exhibiting Mutations in the B-Domain
  64. Altmetric Badge
    Chapter 63 Genetic Variability of the Factor VIII Gene in the Normal Population
  65. Altmetric Badge
    Chapter 64 Three Novel Microdeletions and the First Insertion / Deletion in Patients with Factor X Deficiency
  66. Altmetric Badge
    Chapter 65 SNP Map of the Protein C Gene
  67. Altmetric Badge
    Chapter 66 Characterization of Factor VIII-Von Willebrand Factor (FVIII-VWF)-Complex Concentrates Under Shear Stress
  68. Altmetric Badge
    Chapter 67 Procedural Rules of a National Hemophilia Register in Germany
  69. Altmetric Badge
    Chapter 68 Quality Management of Clotting Factor Replacement Therapy in Medical Institutions — Advantage or Obligation
  70. Altmetric Badge
    Chapter 69 Proteus Syndrome: Successful Therapy of Severe Migraine Symptoms with low Molecular Weight Heparin
  71. Altmetric Badge
    Chapter 70 Administration of Recombinant Factor FVIIa (NovoSeven, NovoNordisk) in a Patient with Glanzmann Thrombasthenia
  72. Altmetric Badge
    Chapter 71 Combined Heterozygous Factor XIII-Deficiency in a Family Case Report
  73. Altmetric Badge
    Chapter 72 Resistance to Coumarin in a 55-year-old Patient with Chronic Arrhythmia
  74. Altmetric Badge
    Chapter 73 Investigation of the Tendency to Bleeding in Patients with low Activity of Plasminogen Activator Inhibitor-1 (PAI-1)
  75. Altmetric Badge
    Chapter 74 The Importance of Pre-Analytic Conditions on the Determination of VWF Parameters
  76. Altmetric Badge
    Chapter 75 Recombinant FVIIa in Chemotherapy Related Thrombocytopenic Bleedings
Attention for Chapter 65: SNP Map of the Protein C Gene
Altmetric Badge

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
SNP Map of the Protein C Gene
Chapter number 65
Book title
34 th Hemophilia Symposium
Published by
Springer, Berlin, Heidelberg, January 2005
DOI 10.1007/3-540-27022-1_65
Book ISBNs
978-3-54-022886-8, 978-3-54-027022-5
Authors

A. Pavlova, C. Geisen, M. Lim-Eimer, M. Watzka, E. Seifried, J. Oldenburg, Pavlova, A., Geisen, C., Lim-Eimer, M., Watzka, M., Seifried, E., Oldenburg, J.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 50%
Student > Master 1 50%
Readers by discipline Count As %
Agricultural and Biological Sciences 1 50%
Medicine and Dentistry 1 50%